))
Pierre Parneix on progress and innovation's role in medical science (France)
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on February 26, 2024 21:31 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 306236366 series 2793147
Content provided by Dr. Marco Bo Hansen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Marco Bo Hansen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ro.player.fm/legal.
On the podcast is Pierre Parneix.
Pierre, a French medical doctor, has specialized in public health and infection control since 1992. He is the president of the French Society for Hospital Hygiene and heads up the southwestern France healthcare-associated infection control center based at the Bordeaux university hospital. Pierre was also one of the members of the COVID-19 commission for France for President Macron.
Pierre focuses his work on antimicrobial resistance surveillance and prevention in hospitals and communication and intervention support in the field of healthcare-associated infection prevention.
On innovation
"Infection control is medical science, so you need to have innovation and change. But sometimes people are very reluctant to change, which is why making the change is difficult."
"We need to show that innovation could help us to decrease the burden on infection but also help the professionals to do things more easily - any innovation should be helpful in some way."
On the cost of outbreaks
"It's known that outbreaks of multidrug-resistant organisms can be very expensive - we need to have progress and innovation in this area."
28 episoade
Distribuie
